mycoworks.com 的前十大競爭對手

ecovative.com

Ecovative, the world's premier mycelium technology company, today announced it has secured over $11 million in its latest funding round to fuel the explosive growth of My®Bacon, the flagship produ ...

grown.bio

Browse through our shop to find exclusive mycelium products, including packaging, interior products, GIY kits and more!

ptcbio.com

What is Huntington’s Disease? Huntington’s disease is a rare, hereditary, genetic disorder of the central nervous system.1 It is caused by a defective gene. This gene produces a protein, called huntingtin, which is involved in the functioning of the nerve cells in the brain (neurons). When the gene is defective, it produces an abnormal (or mutated)…

ataibeckley.com

Explore the therapeutic areas where AtaiBeckley focuses its mental health innovation to address unmet patient needs.

hopkinspsychedelic.org

The Johns Hopkins Psychedelic Research Unit website provides information about or lab, current projects, future directions, and past achievements. Viewers can find media articles and academic publications pertaining to psychedelic research, psilocybin research, psilocybin studies, salvia research, f

zealandpharma.com

Zealand Pharma is a biotechnology company dedicated to developing innovative peptide-based medicines for people living with unmet medical needs

hansabiopharma.com

We develop lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.

leibniz-fmp.de

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, the Faculty of Medicine at Kiel University, and the Leibniz Institute of Virology in Hamburg are jointly receiving funding of nearly one million euros as part of the "Leibniz Cooperative Excellence" program. The goal of the project is to unravel fundamental mechanisms of two-pore domain potassium channels (K2P channels) – with potential new therapeutic approaches for cancer, autoimmune diseases, infectious diseases, central nervous system disorders, and cardiovascular diseases.

nottinghambrc.nihr.ac.uk

the nottingham biomedical research centre (brc) is improving the health of millions of people with common diseases like asthma, depression and arthritis.